Placeholder Banner

IPO Update: 23 IPOs, 11 on Deck

July 23, 2010
Three biotech IPOs were added in the last few months, bringing the total since last August to 23 IPOs. Genmark Diagnostics (US), CorMedix (US), and Novagali (France) each raised under $30M, which is under the median amount raised for all 23 biotech IPOs - globally ($39M) and in the US ($79M) . The post IPO performance continues to be weak, with the median stock performance down over 20%. One of the few stocks in positive territory is Talecris Biotherapeutics, which is now being acquired by Spanish healthcare company Grifols for just over $3B.